Forte Biosciences (FBRX) Capital Expenditures (QoQ) (2016 - 2025)
Forte Biosciences (FBRX) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Forte Biosciences |
70.77 Mn |
12.55 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
96.77% |
| Mar 31, 2024 |
-89.66% |
| Dec 31, 2019 |
148.37% |
| Sep 30, 2019 |
-248.39% |
| Jun 30, 2019 |
-6.77% |
| Mar 31, 2019 |
140.55% |
| Dec 31, 2018 |
-44.49% |
| Sep 30, 2018 |
-144.25% |
| Jun 30, 2018 |
133.18% |
| Mar 31, 2018 |
-30.82% |
| Dec 31, 2017 |
39.47% |
| Sep 30, 2017 |
307.14% |
| Jun 30, 2017 |
5.66% |
| Mar 31, 2017 |
-89.36% |
| Dec 31, 2016 |
251.83% |
| Sep 30, 2016 |
-204.46% |
| Jun 30, 2016 |
665.85% |
